Asensus Surgical Inc. [AMEX: ASXC] closed the trading session at $1.96 on 05/03/21. The day’s price range saw the stock hit a low of $1.92, while the highest price level was $2.12. The company report on April 29, 2021 that Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 11, 2021.
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced that it plans to release 2021 first quarter financial and operating results after the market closes on Tuesday, May 11, 2021. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently webcast.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
To listen to the conference call on your telephone, please dial 1-855-327-6837 for domestic callers and 1-631-891-4304 for international callers, and reference conference ID 10014229 approximately ten minutes prior to the start time. To access the live audio webcast or archived recording, use the following link https://ir.asensus.com/events-and-presentations. The replay will be available on the Company’s website.
The stocks have a year to date performance of 213.60 percent and weekly performance of -17.65 percent. The stock has been moved at 412.69 percent over the last six months. The stock has performed -44.00 percent around the most recent 30 days and changed -39.88 percent over the most recent 3-months.
If compared to the average trading volume of 17.60M shares, ASXC reached to a volume of 6512938 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Asensus Surgical Inc. [ASXC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ASXC shares is $1.45 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ASXC stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Asensus Surgical Inc. is set at 0.32, with the Price to Sales ratio for ASXC stock in the period of the last 12 months amounting to 145.31. The Price to Book ratio for the last quarter was 3.32.
ASXC stock trade performance evaluation
Asensus Surgical Inc. [ASXC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -17.65. With this latest performance, ASXC shares dropped by -44.00% in over the last four-week period, additionally plugging by 412.69% over the last 6 months – not to mention a rise of 363.03% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ASXC stock in for the last two-week period is set at 39.22, with the RSI for the last a single of trading hit 39.45, and the three-weeks RSI is set at 40.71 for Asensus Surgical Inc. [ASXC]. The present Moving Average for the last 50 days of trading for this stock 3.2432, while it was recorded at 2.1240 for the last single week of trading, and 1.6078 for the last 200 days.
Asensus Surgical Inc. [ASXC]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Asensus Surgical Inc. [ASXC] shares currently have an operating margin of -1783.12 and a Gross Margin at -402.90. Asensus Surgical Inc.’s Net Margin is presently recorded at -1868.09.
Return on Total Capital for ASXC is now -91.50, given the latest momentum, and Return on Invested Capital for the company is -98.26. Return on Equity for this stock declined to -101.30, with Return on Assets sitting at -72.71. When it comes to the capital structure of this company, Asensus Surgical Inc. [ASXC] has a Total Debt to Total Equity ratio set at 6.71. Additionally, ASXC Total Debt to Total Capital is recorded at 6.28, with Total Debt to Total Assets ending up at 5.00. Long-Term Debt to Equity for the company is recorded at 3.60, with the Long-Term Debt to Total Capital now at 3.37.
Reflecting on the efficiency of the workforce at the company, Asensus Surgical Inc. [ASXC] managed to generate an average of -$429,797 per employee. Receivables Turnover for the company is 0.87 with a Total Asset Turnover recorded at a value of 0.04.Asensus Surgical Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.30 and a Current Ratio set at 3.30.
Earnings per share (EPS) analysis for Asensus Surgical Inc. [ASXC] stock
With the latest financial reports released by the company, Asensus Surgical Inc. posted -0.41/share EPS, while the average EPS was predicted by analysts to be reported at -0.39/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -5.10%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ASXC.
Asensus Surgical Inc. [ASXC]: Insider Ownership positions
There are presently around $20 million, or 10.00% of ASXC stock, in the hands of institutional investors. The top three institutional holders of ASXC stocks are: VANGUARD GROUP INC with ownership of 2,158,994, which is approximately 18.255% of the company’s market cap and around 0.20% of the total institutional ownership; RENAISSANCE TECHNOLOGIES LLC, holding 1,427,000 shares of the stock with an approximate value of $3.0 million in ASXC stocks shares; and MASTERS CAPITAL MANAGEMENT LLC, currently with $1.89 million in ASXC stock with ownership of nearly 0% of the company’s market capitalization.
Positions in Asensus Surgical Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 34 institutional holders increased their position in Asensus Surgical Inc. [AMEX:ASXC] by around 2,323,179 shares. Additionally, 23 investors decreased positions by around 1,105,571 shares, while 25 investors held positions by with 5,923,046 shares. The mentioned changes placed institutional holdings at 9,351,796 shares, according to the latest SEC report filing. ASXC stock had 16 new institutional investments in for a total of 804,765 shares, while 11 institutional investors sold positions of 133,124 shares during the same period.